Trump Expected to Fire FDA Head Amid Agency Turbulence
Published on 5/8/2026
AI Summary
Marty Makary is reported to be the latest high-profile health official facing termination, as political dynamics shift within the Trump administration. His departure continues a trend of leadership changes affecting key health agencies. This could impact the Food and Drug Administration (FDA) as it navigates ongoing public health challenges. Market reactions to such changes in leadership at the FDA can lead to volatility in healthcare stocks.
Related News
Regulation
FDA Commissioner Marty Makary Resigns Amid Pressure
May 12
Health
FDA Leadership Change Amid Hantavirus Concerns in US
May 12
Regulation
FDA Commissioner Resignation: Marty Makary Steps Down Amid Backlash
May 12
Pharmaceuticals
Revolution Medicines (RVMD) Receives FDA Approval for Daraxonrasib
May 10